- Email: [email protected]
Subject index - volume 22
PROSTAGLANDINS
SUBJECT INDEX - VOLUME ____-___-____-__--__-----
22
Abortion induced 289 trichosanthin 289 Actin binding protein 81 Adenylate cyclase PGE2 95 105 Airway 683, PG12 1013 cyclic-AMP 729 FPL 55712 423 histamine 729 indomethacin 729 Isoproterenol 729 PGE2 729 PGI 729 Airway smooth2muscle FPL 55712 387 leukotrienes 387 Amnion 979 Amniotic fluid PGE2 289 PGF 289 Anesthesia, P "9E 893 Antioxidants, p atelet 255 Aorta, 6-keto PGFlo, 703 Arachidonic acid cyclooxygenase inhibitors deuteration 349 leukotrienes 183 lipoxygenase inhibitors lung 195 lung strip 183 MDCK cells 747 neutrophil 469 PGE2. 747 Arachidonic acid metabolites 195 airway 1013 amnion 979 chondrocytes 499 embryonic tissue 623 gastric circulation 141 HETE 663 kidney 863 oestrus cycle 637 placenta 979 prolactin 433 renal vasculature 567 thyroid 663
183
183
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME -___--_-___--__---__-_-_-
Artery, Aspirin Blood
Body Bone
umbilical 761
22
857
pressure prostacyclin 945 PGE 1003 PGFs2 1003 temperatu're, prostacyclin PGE2 537 PGF& 537 resorption
945
537
Brain arachidonic PGD2 553
metabolites
65
Cervix collagen 117 PGE2 117 PGF 117 Chemotatic dezctivation HETE 279 leukotriene B 279 Chemotaxis, leukotriene4B4 213 Chondrocytes 499 Chromatography, PG12 . 365 Converting enzyme inhibitor 575, 587 Coronary artery PGI 267 U-46619 267 Coronary heart disease 795 platelet sensitivity 713 prostacyclin 773 PGD2 773 PGEl 773 Cyclic-AMP isoproterenol 159 PGE 159 PGI' 159 CyclooxygenasZ kidney 245 products 1013 Cyclooxygenase inhibitors 183, 245 body temperature 945 captopril 587 761 dogs humans 761 macrophage function 411 nerve transmissions 599 renin 587 thyroid 663 vascular resistance 945
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME ------_-------~-~--_-_-_-
Cytoprotection
957,
971
Diabetes mellitus, platelet Diet, leukotrienes 613 13,14-Dihydro-15-keto-PGF2a oestrous cycle oxytocin 443 443 pregnancy Ductus arteriosus 675
sensitivity
773
443
Eicosapentaenoic acid 183, umbilical artery Endoperoxide analogue 81 uterine vasculature Fetal tissue 623 Fibroblast, PGE2 FPL 55712 183 airways Furosemide, PG12
22
613 857 333
723 387, 575
423
Gas chromatography 693 Gastric circulation 141 ulcer 957, 971 Gastrointestinal tract 159 PGE2 205 ulcer 167 Heart
rate PGE2 PGF2ci
1003 1003
HETE 279 HPETE, gastric circulation 141 Hydronephrosis Bradykinin 933 PGE2 933 6-Keto PGFAoarta 703 convulsion 65 extra corporeal circulation normal men 323 platelets 703 trachea 683 ventilation 323 15-Keto-13,14-dihydro-PGF2a, brain
323
65
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME -____-____-___-________--
22
Kidney arachidonic acid metabolites blood flow 513 cortical microsomes 863 cyclooxygenase inhibitors glomerular filtration 245 linoleic acid 747 MDCK cells 747 prostacyclin 715, 783 PGEl 567 PGE 245, 567 2 renln release 455 transplant rejection 783 vasculature 567
863
1
Leukotriene Leukotriene
1013 B4 279 chemotaxis 213 diet 613 human 213 neutropenia 213 polymorph nuclear leucocytes Leukotriene B5, diet 613 Leukotriene C4 airways 387 diet 613 Leukotriene C5, diet 613 Leukotriene 'D4, airway 387 Linoleic acid MDCK cells 747 PGE 747 Lipid peroxidzs 795 Lipoproteins 795 Lipoxygenase, products 1013 Lipoxygenase inhibitor 183 thyroid 663 Lungs arachidonic acid 195 contraction 183 hyperventilation 739 oxygen 11 prostacyclin 323, 739 smoking 195
213
Macrophages cyclic-AMP cyclooxygenase
95 inhibitor
411
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME ___-_--_-__~---~~____~~-_
22
Macrophages phagocytosis phosphodiesterase PGE2 95, 411
411 95
Neutrophil
279 chemiluminescence metabolism 469 Nordihydroguaiaretic acid Oestrus Oxytocin
cycle PGFM 631 PGFM
631, 443
469 183
637
443
Pancreas
Peptide
PGE 2 PGF 2a
35 35
PGI2 a73 vasoactive a73 Phosphodiestrase, PGE2 95 Phospholipase A2, assay 309 Placenta 979 Platelet 773 age aggregation 255, 295, 353, 81, allograft rejection 783 aspirin 761 cyclooxygenase 761 inhibition 255 6-keto-PGF 703 obesity $81 phosphorylation 81 prostacyclin 773, 783, 789 PGD2 773 773 PGE1. sensitivity 773 thromboxane 353 ultrastructure 789 vitamin E 651 vessel wall interaction 703 Polymorph nuclear leucocytes aggregation 213 leukotriene B 213 neutropenia 4213 Pregnancy 131, 631 PGFM 443 Prolactin, PGI 433 2 (continued)
521
PROSTAGLANDINS
SUBJECT INDEX -___-___-_--___-__-___--_
VOLUME
22
Prostacyclin
Prostaglandins,
airway 729 adenylate cyclase 105 allograft rejection 783 blood pressure 945 body temperature 945 captopri 1 575 collecting tubule 715 coronary artery 267 coronary heart disease 795 ductus arteriosus 675 endotoxin shock 739 furosemide 575 heart rate 945 human blood levels 739 hyperventilation 739 inhibition by low density lipoprotein injection 739 isolation 365 kidney 915 liver 915 lung 915 metabolism 915 obesity 521 platelets 773, 783 platelet ultrastructure 789 prolactin 433 pulmonary formation 323 sodium transport 715 thyroid 105 vasoactive peptide a73 venous graft 485 vitamin E 651 analogues 53, 809, 831 assay methodology 693 molecular confirmation 841 uterine artery 223
PGD2 brain 553 cardiovascular effect convulsion 65 nerve transmission platelets 773 renin 455 uterine vasculature
235 599
333 (continued)
795
PROSTAGLANDINS
SUBJECT INDEX VOLUME _----_____--_---____----
PGD3, cardiovascular PGE, PGEl
urine
flow
rate
effect 21
22
235
analogue 167, 957, 971 cyclic-AMP 159 cytoprotection 957, 971 gastric secretion 957, 971 renin 455 PGE2 abortion 289 adenylate cyclase 95 airway 729 arachidonic acid 747 binding site 205 bone resorption 537 Bradykinin 933 chymotrypsinogen 35 collagen 117 convulsion 65 fibroblast 723 gastrointestinal tract 205 glomerular filtration 245 gonadal steroids 377 growing phases 723 Halothane 893 hydronephrosis 933 intracerebroventricular 1003 Iinoleic cells 747 macrophages 411 95, MDCK cells 747 nerve transmission 599 phagocytosis 411 phosphodiesterase 95 renin 455 thymus 377 trachea 683 urine 245 uterine vasculature 333 PGF2
a
abortion 289 airway 729 bone resorption chmotrypsinogen collagen 117 convulsion 65 intracerebroventricular gonadal steroids renin 455
537 35
1003 377
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME ____-__---__----_____----
22
PGF2a semen
903 spermatogenesis thymus 377 trachea 683 uterine vasculature
903
333
PGI2
PG13,
cyclic-AMP 159 uterine vasculature umbilica1 artery 857
333
Renin captopril prostaglandins PGD2 455 PGEl 455 PGE, 455 PGFGa 455 Semen,
PGF2
587 513
903
Thromboxane platelet synthetase
255 inhibitor
353
TXA2 agonist 267, 295 antagonists 295 coronary artery 267 TXB2 convulsion obesity trachea vitamin E
65 521 683 651
Thymus 377 377 Thyroid PG12
105
Trachea 683
Trichosanthin& 289 Trihydroeicosatrienoic Urine Halothane PGE2 893
acid
863
893
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME _____----__-----_-_~----_
22
Uterus arachidonic acid metabolites artery 223 prostaglandin analogue 53 stimulant 53 vasculature 333 Vitamin
Vascular
E platelet PG12 651 TXA 651 resi2stance PGD 235 2 PGD 235 3
255,
651
333
SUBJECT INDEX - VOLUME ____-___-____-__--__-----
22
Abortion induced 289 trichosanthin 289 Actin binding protein 81 Adenylate cyclase PGE2 95 105 Airway 683, PG12 1013 cyclic-AMP 729 FPL 55712 423 histamine 729 indomethacin 729 Isoproterenol 729 PGE2 729 PGI 729 Airway smooth2muscle FPL 55712 387 leukotrienes 387 Amnion 979 Amniotic fluid PGE2 289 PGF 289 Anesthesia, P "9E 893 Antioxidants, p atelet 255 Aorta, 6-keto PGFlo, 703 Arachidonic acid cyclooxygenase inhibitors deuteration 349 leukotrienes 183 lipoxygenase inhibitors lung 195 lung strip 183 MDCK cells 747 neutrophil 469 PGE2. 747 Arachidonic acid metabolites 195 airway 1013 amnion 979 chondrocytes 499 embryonic tissue 623 gastric circulation 141 HETE 663 kidney 863 oestrus cycle 637 placenta 979 prolactin 433 renal vasculature 567 thyroid 663
183
183
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME -___--_-___--__---__-_-_-
Artery, Aspirin Blood
Body Bone
umbilical 761
22
857
pressure prostacyclin 945 PGE 1003 PGFs2 1003 temperatu're, prostacyclin PGE2 537 PGF& 537 resorption
945
537
Brain arachidonic PGD2 553
metabolites
65
Cervix collagen 117 PGE2 117 PGF 117 Chemotatic dezctivation HETE 279 leukotriene B 279 Chemotaxis, leukotriene4B4 213 Chondrocytes 499 Chromatography, PG12 . 365 Converting enzyme inhibitor 575, 587 Coronary artery PGI 267 U-46619 267 Coronary heart disease 795 platelet sensitivity 713 prostacyclin 773 PGD2 773 PGEl 773 Cyclic-AMP isoproterenol 159 PGE 159 PGI' 159 CyclooxygenasZ kidney 245 products 1013 Cyclooxygenase inhibitors 183, 245 body temperature 945 captopril 587 761 dogs humans 761 macrophage function 411 nerve transmissions 599 renin 587 thyroid 663 vascular resistance 945
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME ------_-------~-~--_-_-_-
Cytoprotection
957,
971
Diabetes mellitus, platelet Diet, leukotrienes 613 13,14-Dihydro-15-keto-PGF2a oestrous cycle oxytocin 443 443 pregnancy Ductus arteriosus 675
sensitivity
773
443
Eicosapentaenoic acid 183, umbilical artery Endoperoxide analogue 81 uterine vasculature Fetal tissue 623 Fibroblast, PGE2 FPL 55712 183 airways Furosemide, PG12
22
613 857 333
723 387, 575
423
Gas chromatography 693 Gastric circulation 141 ulcer 957, 971 Gastrointestinal tract 159 PGE2 205 ulcer 167 Heart
rate PGE2 PGF2ci
1003 1003
HETE 279 HPETE, gastric circulation 141 Hydronephrosis Bradykinin 933 PGE2 933 6-Keto PGFAoarta 703 convulsion 65 extra corporeal circulation normal men 323 platelets 703 trachea 683 ventilation 323 15-Keto-13,14-dihydro-PGF2a, brain
323
65
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME -____-____-___-________--
22
Kidney arachidonic acid metabolites blood flow 513 cortical microsomes 863 cyclooxygenase inhibitors glomerular filtration 245 linoleic acid 747 MDCK cells 747 prostacyclin 715, 783 PGEl 567 PGE 245, 567 2 renln release 455 transplant rejection 783 vasculature 567
863
1
Leukotriene Leukotriene
1013 B4 279 chemotaxis 213 diet 613 human 213 neutropenia 213 polymorph nuclear leucocytes Leukotriene B5, diet 613 Leukotriene C4 airways 387 diet 613 Leukotriene C5, diet 613 Leukotriene 'D4, airway 387 Linoleic acid MDCK cells 747 PGE 747 Lipid peroxidzs 795 Lipoproteins 795 Lipoxygenase, products 1013 Lipoxygenase inhibitor 183 thyroid 663 Lungs arachidonic acid 195 contraction 183 hyperventilation 739 oxygen 11 prostacyclin 323, 739 smoking 195
213
Macrophages cyclic-AMP cyclooxygenase
95 inhibitor
411
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME ___-_--_-__~---~~____~~-_
22
Macrophages phagocytosis phosphodiesterase PGE2 95, 411
411 95
Neutrophil
279 chemiluminescence metabolism 469 Nordihydroguaiaretic acid Oestrus Oxytocin
cycle PGFM 631 PGFM
631, 443
469 183
637
443
Pancreas
Peptide
PGE 2 PGF 2a
35 35
PGI2 a73 vasoactive a73 Phosphodiestrase, PGE2 95 Phospholipase A2, assay 309 Placenta 979 Platelet 773 age aggregation 255, 295, 353, 81, allograft rejection 783 aspirin 761 cyclooxygenase 761 inhibition 255 6-keto-PGF 703 obesity $81 phosphorylation 81 prostacyclin 773, 783, 789 PGD2 773 773 PGE1. sensitivity 773 thromboxane 353 ultrastructure 789 vitamin E 651 vessel wall interaction 703 Polymorph nuclear leucocytes aggregation 213 leukotriene B 213 neutropenia 4213 Pregnancy 131, 631 PGFM 443 Prolactin, PGI 433 2 (continued)
521
PROSTAGLANDINS
SUBJECT INDEX -___-___-_--___-__-___--_
VOLUME
22
Prostacyclin
Prostaglandins,
airway 729 adenylate cyclase 105 allograft rejection 783 blood pressure 945 body temperature 945 captopri 1 575 collecting tubule 715 coronary artery 267 coronary heart disease 795 ductus arteriosus 675 endotoxin shock 739 furosemide 575 heart rate 945 human blood levels 739 hyperventilation 739 inhibition by low density lipoprotein injection 739 isolation 365 kidney 915 liver 915 lung 915 metabolism 915 obesity 521 platelets 773, 783 platelet ultrastructure 789 prolactin 433 pulmonary formation 323 sodium transport 715 thyroid 105 vasoactive peptide a73 venous graft 485 vitamin E 651 analogues 53, 809, 831 assay methodology 693 molecular confirmation 841 uterine artery 223
PGD2 brain 553 cardiovascular effect convulsion 65 nerve transmission platelets 773 renin 455 uterine vasculature
235 599
333 (continued)
795
PROSTAGLANDINS
SUBJECT INDEX VOLUME _----_____--_---____----
PGD3, cardiovascular PGE, PGEl
urine
flow
rate
effect 21
22
235
analogue 167, 957, 971 cyclic-AMP 159 cytoprotection 957, 971 gastric secretion 957, 971 renin 455 PGE2 abortion 289 adenylate cyclase 95 airway 729 arachidonic acid 747 binding site 205 bone resorption 537 Bradykinin 933 chymotrypsinogen 35 collagen 117 convulsion 65 fibroblast 723 gastrointestinal tract 205 glomerular filtration 245 gonadal steroids 377 growing phases 723 Halothane 893 hydronephrosis 933 intracerebroventricular 1003 Iinoleic cells 747 macrophages 411 95, MDCK cells 747 nerve transmission 599 phagocytosis 411 phosphodiesterase 95 renin 455 thymus 377 trachea 683 urine 245 uterine vasculature 333 PGF2
a
abortion 289 airway 729 bone resorption chmotrypsinogen collagen 117 convulsion 65 intracerebroventricular gonadal steroids renin 455
537 35
1003 377
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME ____-__---__----_____----
22
PGF2a semen
903 spermatogenesis thymus 377 trachea 683 uterine vasculature
903
333
PGI2
PG13,
cyclic-AMP 159 uterine vasculature umbilica1 artery 857
333
Renin captopril prostaglandins PGD2 455 PGEl 455 PGE, 455 PGFGa 455 Semen,
PGF2
587 513
903
Thromboxane platelet synthetase
255 inhibitor
353
TXA2 agonist 267, 295 antagonists 295 coronary artery 267 TXB2 convulsion obesity trachea vitamin E
65 521 683 651
Thymus 377 377 Thyroid PG12
105
Trachea 683
Trichosanthin& 289 Trihydroeicosatrienoic Urine Halothane PGE2 893
acid
863
893
(continued)
PROSTAGLANDINS
SUBJECT INDEX - VOLUME _____----__-----_-_~----_
22
Uterus arachidonic acid metabolites artery 223 prostaglandin analogue 53 stimulant 53 vasculature 333 Vitamin
Vascular
E platelet PG12 651 TXA 651 resi2stance PGD 235 2 PGD 235 3
255,
651
333